Davidson Kempner Capital Management’s Starling Oncology Warrant STLNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Hold
318,710
– – ﹤0.01% 222
2026
Q1
$17.7K Hold
318,710
– – ﹤0.01% 210
2025
Q4
$38.4K Hold
318,710
– – ﹤0.01% 193
2025
Q3
$38.2K Hold
318,710
– – ﹤0.01% 209
2025
Q2
$16.4K Hold
318,710
– – ﹤0.01% 182
2025
Q1
$8.64K Hold
318,710
– – ﹤0.01% 193
2024
Q4
$1.66K Hold
318,710
– – ﹤0.01% 201
2024
Q3
$6.37K Hold
318,710
– – ﹤0.01% 191
2024
Q2
$6.47K Hold
318,710
– – ﹤0.01% 239
2024
Q1
$63.7K Hold
318,710
– – ﹤0.01% 190
2023
Q4
$39.8K Hold
318,710
– – ﹤0.01% 175
2023
Q3
$27.1K Hold
318,710
– – ﹤0.01% 201
2023
Q2
$8.86K Hold
318,710
– – ﹤0.01% 268
2023
Q1
$19.3K Hold
318,710
– – ﹤0.01% 294
2022
Q4
$35K Hold
318,710
– – ﹤0.01% 309
2022
Q3
$175K Hold
318,710
– – ﹤0.01% 331
2022
Q2
$159K Hold
318,710
– – ﹤0.01% 346
2022
Q1
$367K Hold
318,710
– – ﹤0.01% 375
2021
Q4
$220K Hold
318,710
– – ﹤0.01% 409
2021
Q3
$392K Sell
318,710
-25
-0% -$34 0.01% 349
2021
Q2
$551K Buy
318,735
+58,746
+23% +$79.1K ﹤0.01% 415
2021
Q1
$312K Buy
+259,989
New +$482K ﹤0.01% 406

Other funds holding STLNW

Davidson Kempner Capital Management's STLNW Position: Q2 2026 in Review

Davidson Kempner Capital Management held its Starling Oncology Warrant (STLNW) position steady in Q2 2026 at 318,710 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #222.

Davidson Kempner Capital Management first reported a position in STLNW in Q1 2021 and has held it in 22 quarters since. The position peaked at $551K in Q2 2021. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.

  • Davidson Kempner Capital Management held 318,710 shares of Starling Oncology Warrant worth $13K as of Q2 2026.
  • Davidson Kempner Capital Management left its Starling Oncology Warrant share count unchanged in Q2 2026.
  • Starling Oncology Warrant made up ﹤0.01% of Davidson Kempner Capital Management's portfolio in Q2 2026, its #222 holding.
  • Davidson Kempner Capital Management first reported a position in Starling Oncology Warrant in Q1 2021 and has held it in 22 quarters since.
  • Davidson Kempner Capital Management's Starling Oncology Warrant position peaked at $551K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.